696 related articles for article (PubMed ID: 8593793)
1. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
2. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
3. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
4. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
6. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
Erämaa M; Hildén K; Tuuri T; Ritvos O
Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
[TBL] [Abstract][Full Text] [Related]
7. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
Di Simone N; Hall HA; Welt C; Schneyer AL
Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
[TBL] [Abstract][Full Text] [Related]
8. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341
[TBL] [Abstract][Full Text] [Related]
9. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle.
Halvorson LM; Weiss J; Bauer-Dantoin AC; Jameson JL
Endocrinology; 1994 Mar; 134(3):1247-53. PubMed ID: 8119165
[TBL] [Abstract][Full Text] [Related]
10. Inhibin subunit gene expression in ovarian cancer.
Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
[TBL] [Abstract][Full Text] [Related]
11. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
Delbaere A; Sidis Y; Schneyer AL
Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
[TBL] [Abstract][Full Text] [Related]
12. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
Alexander JM; Swearingen B; Tindall GT; Klibanski A
J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
[TBL] [Abstract][Full Text] [Related]
13. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.
Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW
Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
15. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes.
Sidis Y; Fujiwara T; Leykin L; Isaacson K; Toth T; Schneyer AL
Biol Reprod; 1998 Oct; 59(4):807-12. PubMed ID: 9746729
[TBL] [Abstract][Full Text] [Related]
16. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
17. Sex difference in the action of activin-A on cell proliferation of differentiating rat gonad.
Kaipia A; Toppari J; Huhtaniemi I; Paranko J
Endocrinology; 1994 May; 134(5):2165-70. PubMed ID: 8156918
[TBL] [Abstract][Full Text] [Related]
18. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
19. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
20. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
